A new directive issued by the Ministry of Health is reshaping the country’s medical travel landscape by placing legal responsibility on third-party agents who arrange treatment abroad.
The Overseas Medical Service Referral System Implementation Directive introduces sweeping changes to how Ethiopian patients are referred to and treated in foreign healthcare facilities. Most notably, it establishes an accountability framework for locally licensed medical referral agents.
Under the directive, agents are now legally required to compensate patients for harm arising from medical errors, professional negligence, or substandard care received in foreign hospitals. This provision addresses a long-standing gap, where patients previously had little or no legal recourse when malpractice occurred outside Ethiopia’s jurisdiction.
To enforce this obligation, the Ministry has tightened eligibility criteria for agents. Only licensed health professionals are permitted to operate as referral agents, and they must present verified documentation confirming that their partner institutions abroad hold recognized national or international quality certifications.
The directive also introduces stricter oversight measures. Agents who fail to adequately support patients or who misrepresent foreign medical facilities face administrative sanctions ranging from formal warnings to the revocation of their Certificate of Competence.
In addition, agents are required to provide continuous assistance throughout the patient’s treatment journey. If a foreign hospital refuses to treat a referred patient after arrival, the agent must notify the Ministry within one working day.
The new liability framework is expected to incentivize agents to conduct more rigorous due diligence when selecting foreign healthcare providers, while offering Ethiopian patients an added layer of protection when seeking treatment overseas.
Beyond regulating agents, the directive reinforces state control over outbound medical referrals. Patients must obtain prior authorization from the Ministry, supported by medical evidence demonstrating that the required treatment is unavailable domestically, that delays could result in irreversible harm, or that ongoing treatment abroad necessitates continuation.
Financial requirements have also been formalized. Patients must present proof of a minimum bank deposit of 500,000 Birr, which rises to one million Birr for transplant procedures.
Only designated comprehensive specialized hospitals—or, where unavailable, approved general hospitals—are authorized to issue foreign medical referral board certificates. These institutions are required to submit updated records of board members and their specimen signatures to the relevant authorities.
Overall, the directive marks a significant policy shift, strengthening patient protection while imposing stricter accountability and compliance standards across Ethiopia’s growing medical travel sector.
